Matrix metalloproteinase-9 and intercellular adhesion molecule 1 are powerful staging markers for human African trypanosomiasis

Tropical Medicine and International Health

Volumn 16, Issue 1, 2011, Pages 119-126

  Hainard, Alexandre ^a   Tiberti, Natalia ^a   Robin, Xavier ^a   Ngoyi, Dieudonné M ^b   Matovu, Enock ^c   Enyaru, John C K ^c   Müller, Markus ^d   Turck, Natacha ^a   Ndung'u, Joseph M ^e   Lejon, Veerle ^f   Sanchez, Jean Charles ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b Institut National de Recherche Biomedicale   (Congo)

^c MAKERERE UNIVERSITY   (Uganda)

^d SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^e FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

^f INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Cerebrospinal fluid; Human African trypanosomiasis; ICAM 1; MMP 9; Stage determination

Indexed keywords

BIOLOGICAL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FATTY ACID BINDING PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE A; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; VASCULAR CELL ADHESION MOLECULE 1;

BLOOD; BRAIN; DISEASE INCIDENCE; DISEASE TREATMENT; ENZYME ACTIVITY; MOLECULAR ANALYSIS; PARASITE INFESTATION; TRYPANOSOMIASIS;

ABSENCE; ADOLESCENT; ADULT; AFRICAN TRYPANOSOMIASIS; ARTICLE; CEREBROSPINAL FLUID LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLEX BEAD SUSPENSION ASSAY; NEUROLOGIC DISEASE; PARASITE IDENTIFICATION; SENSITIVITY AND SPECIFICITY; TRYPANOSOMA;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS; CHEMOKINES; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMIASIS, AFRICAN; YOUNG ADULT;

TRYPANOSOMA BRUCEI GAMBIENSE;

EID: 78650215856     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2010.02642.x     Document Type: Article

References (29)

1. Agrawal S, Anderson P, Durbeej M et al. (2006) Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. The Journal of Experimental Medicine 203, 1007-1019.
2. Amin DN, Rottenberg ME, Thomsen AR et al. (2009) Expression and role of CXCL10 during the encephalitic stage of experimental and clinical African trypanosomiasis. The Journal of Infectious Diseases 200, 1556-1565.
3. Brown HC, Chau TT, Mai NT et al. (2000) Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam. Neurology 55, 104-111.
4. Brun R, Blum J, Chappuis F & Burri C (2010) Human African trypanosomiasis. The Lancet 375, 148-159.
5. Chappuis F, Loutan L, Simarro P, Lejon V & Buscher P (2005) Options for field diagnosis of human African trypanosomiasis. Clinical Microbiology Reviews 18, 133-146.
6. Courtioux B, Pervieux L, Vatunga G et al. (2009) Increased CXCL-13 levels in human African trypanosomiasis meningo-encephalitis. Tropical Medicine & International Health 14, 529-534.
7. Enanga B, Burchmore RJ, Stewart ML & Barrett MP (2002) Sleeping sickness and the brain. Cellular and Molecular Life Sciences 59, 845-858.
8. Girard M, Giraud S, Courtioux B, Jauberteau-Marchan M & Bouteille B (2005) Endothelial cell activation in the presence of African trypanosomes. Molecular and Biochemical Parasitology 139, 41-49.
9. Grab DJ & Kennedy PG (2008) Traversal of human and animal trypanosomes across the blood-brain barrier. Journal of Neurovirology 14, 344-351.
10. Hainard A, Tiberti N, Robin X et al. (2009) A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients. PLoS Neglected Tropical Diseases 3, e459.
11. Jaber S, Hamed E & Hamed S (2009) Adhesion molecule levels in serum and cerebrospinal fluid in children with bacterial meningitis and sepsis. Journal of Pediatric Neurosciences 4, 76-85.
12. Kennedy PG (2008) The continuing problem of human African trypanosomiasis (sleeping sickness). Annals of Neurology 64, 116-126.
13. Kristensson K, Nygård M, Bertini G & Bentivoglio M (2010) African trypanosome infections of the nervous system: parasite entry and effects on sleep and synaptic functions. Progress in Neurobiology 91, 152-171.
14. Leib SL, Leppert D, Clements J & Täuber MG (2000) Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infection and Immunity 68, 615-620.
15. Lejon V, Lardon J, Kenis G et al. (2002) Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of Trypanosoma brucei gambiense sleeping sickness patients before and after treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 96, 329-333.
16. Liuzzi GM, Trojano M, Fanelli M et al. (2002) Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis. Multiple Sclerosis 8, 222-228.
17. Luster AD, Alon R & von Andrian UH (2005) Immune cell migration in inflammation: present and future therapeutic targets. Nature Immunology 6, 1182-1190.
18. Man S, Ubogu EE & Ransohoff RM (2007) Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathology 17, 243-250.
19. McClish DK (1989) Analyzing a portion of the ROC curve. Medical Decision Making 9, 190-195.
20. Mulenga C, Mhlanga JD, Kristensson K & Robertson B (2001) Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model. Neuropathology and Applied Neurobiology 27, 77-85.
21. Mumba Ngoyi D, Lejon V, Pyana P et al. (2010) How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness. The Journal of Infectious Diseases 201, 453-463.
22. Petruzzelli L, Takami M & Humes HD (1999) Structure and function of cell adhesion molecules. The American Journal of Medicine 106, 467-476.
23. Radi ZA, Kehrli ME & Ackermann MR (2001) Cell adhesion molecules, leukocyte trafficking, and strategies to reduce leukocyte infiltration. Journal of Veterinary Internal Medicine 15, 516-529.
24. Ransohoff RM, Kivisakk P & Kidd G (2003) Three or more routes for leukocyte migration into the central nervous system. Nature Reviews Immunology 3, 569-581.
25. Rodgers J (2009) Human African trypanosomiasis, chemotherapy and CNS disease. Journal of Neuroimmunology 211, 16-22.
26. Rosenberg GA (2009) Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurology 8, 205-216.
27. Tsai H, Chung L, Chen E et al. (2008) Association of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinase-4 in cerebrospinal fluid with blood-brain barrier dysfunction in patients with eosinophilic meningitis caused by angiostrongylus cantonensis. The American Journal of Tropical Medicine and Hygiene 78, 20-27.
28. Van den Steen PE, Van Aelst I, Starckx S, Maskos K, Opdenakker G & Pagenstecher A (2006) Matrix metalloproteinases, tissue inhibitors of MMPs and TACE in experimental cerebral malaria. Laboratory Investigation 86, 873-888.
29. WHO (1998) Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee. World Health Organization Technical Report Series 881, 1-114.